Pruritus Therapeutic Market Set to Reach $22.02 Billion by 2029 with 9% Yearly Growth

What industry-specific factors are fueling the growth of the pruritus therapeutic market?
The rising occurrences of skin ailments are playing a major role in propelling the pruritus therapeutic market. The term 'skin conditions' encompasses a variety of dermatological disorders, including acne, eczema, skin cancer, psoriasis, and vitiligo, all of which impact the skin. As pruritus is a prevailing symptom in most skin diseases, pruritus therapeutics are frequently employed as a part of the treatment regime. For example, the American Academy of Dermatology Association, a US-based dermatology association, stated in April 2022 that melanoma is anticipated to result in the death of 7,650 individuals in 2022, composed of 5,080 males and 2,570 females. Moreover, the American Cancer Society, a voluntary organization based in the US, reported in January 2023 that an estimated 97,610 fresh cases of melanoma are predicted to be detected in the United States in 2023, with approximately 58,120 occurring in men and 39,490 in women. Thus, the increasingly frequent instances of skin conditions act as a catalyst for the pruritus therapeutic market.

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

What Is the projected market size and growth rate for the pruritus therapeutic market?
In recent times, the market size for pruritus therapy has experienced robust growth. The market, which is projected to expand from $14.29 billion in 2024 to $15.43 billion in 2025, is set to display a compound annual growth rate (CAGR) of 8.0%. The notable growth observed in the historic period can be ascribed to factors such as the rising occurrence of pruritus, progress in research and development, an expanding elderly population, the enhancement of healthcare infrastructure, heightened patient awareness, and collaborative partnerships.

There is an anticipation of significant expansion in the pruritus therapeutic market size in the upcoming years. It is projected to escalate to $22.02 billion by 2029, experiencing a compound annual growth rate (CAGR) of 9.3%. Variables contributing to the growth during the forecast period encompass ongoing research and advancement, growth of emerging markets, increased healthcare spending, trend towards personalized medicine, and regulatory backing for innovation. Foreseen trends during the forecast period involve the integration of telemedicine and digital health, advancements in technology, telehealth and digital health solutions, global regulatory landscapes, biologics and immunomodulators, and patient-focused strategies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

What new trends are reshaping the pruritus therapeutic market and its opportunities?
In the pruritus therapeutic market, product innovation is becoming increasingly popular. This trend sees leading market players dedicating their efforts to the creation of novel medications and treatments for pruritus and similar ailments. An example of this occurred in August 2022, when Japanese pharmaceutical company Maruho Co., Ltd released an anti-IL-31 receptor, a humanised monoclonal antibody Mitchga Subcutaneous Injection 60 mg Syringes, designed to address itching associated with atopic dermatitis. It's the pioneer antibody drug that blocks IL-31 signaling, a neuroimmune cytokine closely related to pruritus and skin inflammation in atopic dermatitis progression. The compound prevents IL-31 from binding with its receptor, thereby lowering itchiness and skin inflammation linked to atopic dermatitis.

What major market segments define the scope and growth of the pruritus therapeutic market?
The pruritus therapeutic market covered in this report is segmented -

1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types
2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
3) By Application: External Use, Oral, Injection
4) By End Use: Hospitals, Clinics, Other Uses

Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics, Injectable Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Systemic Immunosuppressants, Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus, Pimecrolimus
7) By Other Types: Antidepressants, Phototherapy Treatments, Herbal Remedies

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9925

Which region dominates the pruritus therapeutic market?
North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the pruritus therapeutic industry growth?
Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

What Is Covered In The Pruritus Therapeutic Global Market Report?

• Market Size Forecast: Examine the pruritus therapeutic market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the pruritus therapeutic market for a structured understanding.
• Key Players Overview: Analyze major players in the pruritus therapeutic market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pruritus therapeutic market.
• Segment Contributions: Evaluate how different segments drive overall growth in the pruritus therapeutic market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pruritus therapeutic market.
• Industry Challenges: Identify potential risks and obstacles affecting the pruritus therapeutic market.
• Competitive Landscape: Review strategic developments in the pruritus therapeutic market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.